Parametric Portfolio Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$16.5M Sell
269,677
-4,903
-2% -$255K 0.01% 1074
2021
Q4
$14.4M Buy
274,580
+59,385
+28% +$2.49M 0.01% 1153
2021
Q3
$8.02M Sell
215,195
-20,676
-9% -$719K ﹤0.01% 1506
2021
Q2
$9.63M Buy
235,871
+119,017
+102% +$4.4M 0.01% 1424
2021
Q1
$3.96M Buy
116,854
+3,530
+3% +$122K ﹤0.01% 2330
2020
Q4
$3.6M Sell
113,324
-40,707
-26% -$1.07M ﹤0.01% 2293
2020
Q3
$3.95M Buy
154,031
+32,305
+27% +$737K ﹤0.01% 2059
2020
Q2
$3.13M Buy
121,726
+19,556
+19% +$396K ﹤0.01% 2209
2020
Q1
$1.57M Buy
102,170
+50,491
+98% +$1.1M ﹤0.01% 2531
2019
Q4
$1.77M Buy
51,679
+9,667
+23% +$116K ﹤0.01% 2766
2019
Q3
$314K Sell
42,012
-9,821
-19% -$94.2K ﹤0.01% 3508
2019
Q2
$673K Buy
51,833
+7,223
+16% +$92.6K ﹤0.01% 3242
2019
Q1
$543K Buy
44,610
+28,501
+177% +$364K ﹤0.01% 3293
2018
Q4
$183K Sell
16,109
-4,934
-23% -$79.7K ﹤0.01% 3679
2018
Q3
$457K Buy
21,043
+331
+2% +$6.92K ﹤0.01% 3448
2018
Q2
$366K Sell
20,712
-33,077
-61% -$672K ﹤0.01% 3476
2018
Q1
$1.13M Buy
53,789
+34,419
+178% +$670K ﹤0.01% 2952
2017
Q4
$280K Buy
19,370
+4,416
+30% +$68.2K ﹤0.01% 3602
2017
Q3
$236K Buy
+14,954
New +$219K ﹤0.01% 3785
2017
Q2
Sell
-92,971
Closed -$1.51M 4042
2017
Q1
$1.51M Buy
92,971
+75,027
+418% +$1.09M ﹤0.01% 2630
2016
Q4
$271K Sell
17,944
-10,096
-36% -$143K ﹤0.01% 3476
2016
Q3
$427K Buy
28,040
+3,407
+14% +$138K ﹤0.01% 3243
2016
Q2
$956K Buy
24,633
+14,870
+152% +$534K ﹤0.01% 2862
2016
Q1
$271K Buy
9,763
+5,220
+115% +$174K ﹤0.01% 3642
2015
Q4
$244K Buy
+4,543
New +$229K ﹤0.01% 3645

Other funds holding ITCI